loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Sumatriptan Succinate

    Menu

    Sumatriptan Succinate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,007Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 22239 / DOSAGE - INJECTABLE;SUBCUTANEOUS - EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SUMATRIPTAN SUCCINATE(UNII: J8BDZ68989)
    (SUMATRIPTAN - UNII:8R78F6L9VO)     		SUMATRIPTAN4mg in 0.5 | 6mg in 0.5

    Inactive Ingredients

    Ingredient Name
    A-S Medication Solutions
    AGILA SPECIALTIES PRIVATE LIMITED
    Baxter Healthcare Corporation
    Caplin Steriles Limited
    Endo Pharmaceuticals, Inc.
    Glaxo Operations UK Ltd
    Mylan Institutional LLC
    Prasco Laboratories
    Proficient Rx LP
    Sagent Pharmaceuticals
    Sandoz Inc
    Somerset Therapeutics, LLC
    Teva Parenteral Medicines, Inc.
    Wockhardt Limited
    Wockhardt USA LLC.
    SODIUM CHLORIDE(451W47IQ8X)
    WATER(059QF0KO0R)